CDC Website CDC Website

To Join the NPIN community or

Home » HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

American Association for the Study of Liver Diseases and the Infectious Disease Society of America
Recommendations for Testing, Managing, and Treating Hep C (PDF)

The landscape of treatment for hepatitis C virus (HCV) infection has evolved substantially since the introduction of highly effective HCV protease inhibitor therapies in 2011. The pace of change has increased rapidly as numerous new drugs with different mechanisms of action have become available over the past few years. To provide healthcare professionals with timely guidance as new therapies become available and are integrated into HCV regimens, the Infectious Diseases Society of America (IDSA) and American Association for the Study of Liver Diseases (AASLD), developed a web-based process for the rapid formulation and dissemination of evidence-based, expert-developed recommendations for hepatitis C management.

Audiences
Health Professionals
Author
American Association for the Study of Liver Diseases and the Infectious Disease Society of America
Disease
Viral Hepatitis
Subjects
Hepatitis C
Year of Publication
2021
Format
Report

Last Updated Date: 

10/28/22

Publication ID: 

365761